Clinical Trial Update: Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 study exploring trebananib in combination with temsirolimus for adults with metastatic or unresectable solid tumors, including neuroendocrine tumors, re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor of the Lung
• Neuroendocrine Tumor Gastrointestinal
• Renal Cell Carcinoma
• Uterine Sarcoma

Drugs mentioned

• Temsirolimus (temsirolimus)
• Trebananib (trebananib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Solid Neoplasm, Lung Carcinoid Tumor | Phase 1 | Status: COMPLETED